KCNJ2 and short QT syndrome type 3: Disruptions and enhancement in channel trafficking can lead to alterations in KIR2.1 ion channel expression on the cell surface, which can lead to diseases like ATS, and SQT3 (Ambrosini et al. 2014; Bendahhou et al. 2003).